MedTrace Logo

The Adjustment of Doses in Diabetes Mellitus Type I

NCT06055829 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2023-09-28

No results posted yet for this study

Summary

The study was carried out in a diabetic patient who was starting a new approach for treatment. Previously the patient was treated with Novo-mix insulin injection twice per day, the physician decided to change the treatment strategy to be with three doses of novo-rapid insulin injections per day plus one injection of Lantus SoloStar in dinner. For two weeks we were monitoring the blood glucose level by the FreeStyle Libre sensor. Moreover, the right statistical technique was used for data analysis.

Conditions

  • Diabetes Mellitus, Type 1

Interventions

DRUG

Insulin injection and blood glucose

The FreeStyle Libre sensor continuously measures glucose every minute and saves the glucose data. Scan the sensor at least every 8 hours for a full glycemic profile. The below data is displayed after a typical 1-second scan of the FreeStyle LibreLink app or FreeStyle Libre reader via the sensor:

Sponsors & Collaborators

  • Liwa College

    lead OTHER

Eligibility

Min Age
41 Years
Max Age
41 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-24
Primary Completion
2022-11-06
Completion
2023-01-20
FDA Drug
Yes

Countries

  • United Arab Emirates

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06055829 on ClinicalTrials.gov